Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
6.77M
-
Number of holders
-
23
-
Total 13F shares, excl. options
-
1.82M
-
Shares change
-
+1.41M
-
Total reported value, excl. options
-
$29.1M
-
Value change
-
+$22.4M
-
Number of buys
-
18
-
Number of sells
-
-3
-
Price
-
$16.78
Significant Holders of DarioHealth Corp. - Common Stock, par value $0.0001 per share (DRIO) as of Q3 2020
24 filings reported holding DRIO - DarioHealth Corp. - Common Stock, par value $0.0001 per share as of Q3 2020.
DarioHealth Corp. - Common Stock, par value $0.0001 per share (DRIO) has 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.82M shares
of 6.77M outstanding shares and own 26.9% of the company stock.
Largest 10 shareholders include Phoenix Holdings Ltd. (669K shares), Nantahala Capital Management, LLC (594K shares), FRIESS ASSOCIATES LLC (121K shares), VANGUARD GROUP INC (99.3K shares), MEITAV DASH INVESTMENTS LTD (86.9K shares), DRIEHAUS CAPITAL MANAGEMENT LLC (40K shares), ROYAL BANK OF CANADA (39.3K shares), GEODE CAPITAL MANAGEMENT, LLC (25.8K shares), GOLDMAN SACHS GROUP INC (25.2K shares), and IPG Investment Advisors LLC (24.7K shares).
This table shows the top 23 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.